Core Viewpoint - Spectral AI Inc. is raising $7.6 million to enhance its balance sheet and support the development of its DeepView System, aiming for commercial readiness by 2026 [1][2][3]. Group 1: Capital Raise Details - The company plans to issue 4 million shares of common stock at a price of $1.90 per share, along with corresponding warrants priced at $2.51 per share [2]. - The capital raised will facilitate the expansion of clinical indications for the DeepView System [2][3]. Group 2: Company Overview - Spectral AI Inc. specializes in medical diagnostics using AI and multispectral imaging to evaluate wound healing potential [4]. - The technology developed by the company aids clinicians in making quicker and more accurate treatment decisions for patients suffering from burns and diabetic foot ulcers [4]. Group 3: Strategic Commitment - The company remains committed to its current BARDA Project BioShield (PBS) contract while advancing its AI technology to enhance product offerings [3].
Spectral AI Inc. (MDAI) Eyes $7.6M Capital Raise to Accelerate DeepView System Development